sought to examine if race is associated with postpartum readmission due to hypertension in women with pregnancy-associated hypertension. STUDY DESIGN: This was a multi-institutional retrospective cohort study of all women with pregnancy-associated hypertension diagnosed prior to initial discharge from January 2009 to December 2016. Pregnancy-associated hypertension such as gestational hypertension and preeclampsia (with or without severe features) was diagnosed based on American College of Obstetricians and Gynecologists Task Force definitions. Women with chronic hypertension and superimposed pre-eclampsia were excluded. Postpartum readmission due to hypertension was defined as a readmission due to severe hypertension within 6 weeks postpartum. Outcomes including age, gestational age, race/ethnicity (self-reported), body mass index (kg/m 2 ), marital status, type of pregnancy-associated hypertension, diabetes (gestational or pregestational), use of antihypertensive drugs, mode of delivery, and others were utilized in the comparison. Multivariable logistic regression models were performed to calculate adjusted odds ratios (OR) and 95% confidence interval (95%CI). RESULTS: Of 4,949 women with pregnancy-associated hypertension before initial discharge, 71 (1.4%) had postpartum readmission due to hypertension. Women with postpartum readmission due to hypertension compared to those without were more likely to be older (P <. 001) ( Table 1 ). Other outcomes were comparable. After adjusting for confounders, women with postpartum readmission due to hypertension compared to those without were more likely to be older (adjusted OR 1.04; 95%CI 1.00-1.09) and non-Hispanic black (adjusted OR 2.31; 95%CI 1.05-5.08; non-Hispanic white as referent) (Table 2) CONCLUSION: In women with pregnancy-associated hypertension before initial discharge, non-Hispanic black women were at increased odds of postpartum readmission due to hypertension. Further studies are required to reduce racial disparities in postpartum readmission due to hypertension.
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506 A population-based definition for severe proteinuria and its association with adverse outcomes in preeclampsia 
OBJECTIVE:
In preeclampsia (PE), the association between the degree of proteinuria and adverse outcomes remains unclear. The historical definition of severe proteinuria (>5g protein in a 24-hr urine collection) was likely too restrictive as few women exceed that mark. We sought to define severe proteinuria in our study population and to determine if its presence associates with adverse outcomes in PE. STUDY DESIGN: Retrospective cohort study of subjects delivered 23 weeks' gestation at a single institution (Oct '13 e Apr '18) with a hypertensive disorder of pregnancy [chronic hypertension, gestational hypertension, PE, or preeclampsia with severe features (PE-SF)]. Subjects were identified by ICD-9/ICD-10 discharge codes, followed by individual chart review. From study subjects, the 90 th percentile for protein in a 24-hr urine collection or protein/creatinine (P/C) ratio from a random (spot) specimen was determined. These values were used as the cut-point to define severe proteinuria in our analytic sample. We then compared adverse neonatal and maternal outcomes between those with and without severe proteinuria. Data were analyzed by Fisher's exact, t-test, and logistic regression, with a¼0.05.
RESULTS: From 10,833 deliveries, 1,487 (13.7%) were classified with a hypertensive disorder of pregnancy. The 90 th percentile for urine protein on a 24-hr specimen was 1,580 mg, and for urine P/C ratio on a random specimen was 1.75. Among 396 women with PE-SF, 78 (19.7%) had severe proteinuria >90 th percentile. Subjects with severe proteinuria were younger, had a lower BMI, more likely to be nulliparous and covered by public insurance compared to PE-SF subjects without severe proteinuria (Table 1) . Severe proteinuria was associated with more severe systolic and diastolic blood pressures (p<0.001 and p¼0.047, respectively) as well as any severe feature of PE (p¼0.016). They also had worse composite neonatal outcomes (p¼<0.001) which remained significant after multivariable adjustment (aOR: 2.92, p<0.001) ( Table 2 ). Most notably, the odds of preterm birth <34 weeks was increased 4.8 times in women with PE-SF and severe proteinuria compared to those with PE-SF but without severe proteinuria (p<0.001). CONCLUSION: We demonstrate that severe proteinuria, as defined by population-based data, shows a strong association with adverse neonatal outcomes and preterm birth in women with preeclampsia. OBJECTIVE: Race specific assessment of pregnancy is important as it allows the identification of women who are at an increased risk of certain pathology and enhanced monitoring. This study explored the association between angiogenic markers (soluble fms-like tyrosine kinase-1 [sFlt1] and placental growth factor [PlGF]) in African American (AA) and white women who were normotensive and those with hypertensive disorders of pregnancy (HDP). STUDY DESIGN: Normotensive women and those HDP were enrolled upon admission and blood samples were collected within 96 hours prior to delivery. Angiogenic markers were measured on an automated platform. Data was collected from medical records. For analysis patients were stratified into having a HDP or not. RESULTS: Data was collected on a total of 608 women, of which 477 (78%) were black and 131 (22%) were white. Age, infant birthweight and the prevalence of nulliparity was significantly higher in white women as compared to AA women (Table 1) . On the contrary, body mass index was significantly higher in AA women as compared to white women (median BMI 28.1 vs 25.8; p¼0.01). Other interventions including antepartum medication administration was similar between groups.
When comparing angiogenic profiles, the median PlGF was significantly higher (p¼0.001) and the median sFlt1/PlGF was lower (p¼0.03) among AA women as compared to white women, regardless of hypertensive status. No difference was seen between sFlt1 and racial group (p¼0.80).
Consistent with previous studies by our group and others, abnormal angiogenic factors were observed among patients with a HDP. When stratifying by hypertensive status (within or without a HDP), the relationship between PlGF and race persisted. Unexpectedly, this was most pronounced among normotensive women, as AA women experienced a higher median PlGF of 245 pg/mL (interquartile range 133-495) as compared to a median PlGF of 151 pg/mL (IQR: 75-250) in white women (Table 2) . CONCLUSION: This study demonstrates a significant association between PlGF and race. Additional evaluation of the role of angiogenic markers during assessment for HDP in AA women as compared to white women and disease severity is needed. Factors other than angiogenic factors needs to be evaluated to explain higher prevalence of HDP in AA women.
